{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2008"],"condition":["Colorectal Neoplasms","Unresectable or Metastatic Colorectal Cancer"],"disease":["Colorectal Neoplasms","Unresectable Or Metastatic Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2054702"],"location":["Japan"],"study_start_month":["5"],"keyword":["Irinotecan","Sunitinib","Levoleucovorin","Leucovorin","Fluorouracil"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Study Of Sunitinib With FOLFIRI In Colorectal Cancer","description":"To evaluate the efficacy, safety and pharmacokinetics of sunitinib plus FOLFIRI (irinotecan, 5-FU and l-leucovorin) in the first-line treatment of Japanese mCRC patients","dates":{"creation":"2008-05-15"},"accession":"2054702","cross_references":{"ClinicalTrials___gov":["NCT00668863"]}}